ClinicalTrials.gg
RecruitingNCT05892172Updated Jun 29, 2023

Heart Failure and Sleep Disordered Breathing

An observational study in Heart Failure, sponsored by Yihui Kong. Recruiting at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-29.

Sponsored by Yihui Kong · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2024, 2 years 10 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
300
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 377 studies in Heart Failure with a site in China — 162 open to participants now, 182 under way, 18 of them phase 3. Heart Failure · China.

Planned enrollment
82nd of 130
300 · median 554
Started
2023
with 42 others
Observational
130 of 377
64 open now
Primary completion
2024-01
later than 5 of 181 live
Registered
205th of 377
by date

Among the 377 studies in Heart Failure with a site in China, this one is the 82nd largest by planned enrollment of the 130 observational ones that give a count, is one of 43 that started in 2023, is one of 130 observational ones, reaches primary completion later than 5 of the 181 other live ones, and was the 205th registered.

Heart Failure

6,340 studies on the registry are indexed under Heart Failure; 1,397 are open to participants now.

Browse Heart Failure studies →

Open to participants now

162 of the 377 studies in Heart Failure with a site in China are open now. Recruiting first, the newest first:

157 more — sign in →

All 162 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 968 Heart Failure studies recruiting now, 691 (71%) set no upper age limit and 90 (9%) stop at 75 or younger; 64 take children under 18; 97 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 377 studies in Heart Failure with a site in China, or all of them as a file.
02

Study summary

The purpose of this study is to analyze and summarize the characteristics of arrhythmia and heart rate variability of Chinese patients with three different types of heart failure combined with sleep disordered breathing based on the clinical data, to provide new diagnosis and treatment ideas for domestic patients, and then to improve the prognosis of patients betterly.

03

Conditions studied

  • Heart Failure

Keywords

  • sleep disordered breathing
  • arrhythmia
  • heart rate variability
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Heart failure patients hospitalized in the Department of Cardiology of the First Affiliated Hospital of Harbin Medical University

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age >18 years.
  2. The diagnosis of heart failure conforms to the criteria of the Chinese Guidelines for the Diagnosis and Treatment of Heart Failure .
  3. Echocardiography, dynamic and polysomnography monitoring should be improved during the period of hospitalization.
  4. Patients with sleep apnea have not received standard treatment.

Exclusion criteria

Exclusion Criteria:

  1. Patients undergoing cardiac surgery in the past 6 weeks.
  2. Patients with acute decompensated heart failure or heart failure requiring oxygen therapy.
  3. All patients with sleep apnea who receive standard treatment.
  4. Patients who use pacemakers or implantable cardioverter defibrillators.
  5. The patient did not complete the echocardiography, dynamic , and polysomnography monitoring during hospitalization.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ECG (electrocardiogram)

A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • HFrEF group

    HFrEF was defined as Left ventricular ejection fraction ≤40%

  • HFmrEF group

    HFmrEF was defined as Left ventricular ejection fraction 41%\~49%

  • HFpEF group

    HFpEF was defined as Left ventricular ejection fraction ≥50%

06

What researchers measure

Primary outcomes

  1. heart failure and sleep apnea

    analyze and summarize the characteristics of arrhythmia and heart rate variability of Chinese patients with three different types of heart failure combined with sleep-disordered breathing based on the clinical data. Collection of clinical data: general clinical data, physical signs, post-admission inspection indicators, and treatment conditions of patients collected from the electronic medical record system. Echocardiographic data mainly included ejection fraction, left atrial anterior-posterior diameter, and interventricular septum thickness, which were in millimeters; electrocardiogram examination mainly included Diagnosis type of arrhythmia by dynamic, the overall standard deviation of normal sinus R-R interval (SDNN), the average standard deviation of normal sinus R-R interval throughout the recording period (SDANN), which were in a millisecond, etc; The type and severity of sleep-disordered breathing and Apnea hypopnea index were obtained by polysomnography.

    Time frame: 24 hours

07

Study locations

1 of 1 sites recruiting
  • Yihui Kong
    Harbin, Heilongjiang 150000, China
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2023; primary completion for Jan 2024, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
May 18, 2023
First posted
Jun 7, 2023
StartEst.
Jun 28, 2023
Primary completionEst.
Jan 1, 2024
CompletionEst.
Apr 30, 2024
Last update
Jun 29, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05892172
Lead sponsor
Yihui Kong
Responsible party
Yihui Kong (Professor, First Affiliated Hospital of Harbin Medical University) — Sponsor-investigator
First posted
Jun 7, 2023
Start date
Jun 28, 2023 (estimated)
Primary completion
Jan 1, 2024 (estimated)
Completion
Apr 30, 2024 (estimated)
Last update
Jun 29, 2023

Study contacts

Yihui Kong, M.D.
Contact
kongyihui@126.com
85555672

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion